← back to search

Varun Chaudhary

Singapore National Eye Center ·
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Imaging and Analysis, Ophthalmology and Visual Impairment Studies, and Retinal and Macular Surgery.
h-index
27
citations
2,333
works
155
NIH funding
primary concept
email

Recent publications

Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries
American Journal of Ophthalmology 2025cited by 43position: middledoi
Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmology 2025cited by 11position: lastdoi
Choriocapillaris in Age-Related Macular Degeneration: A Systematic Review of Optical Coherence Tomography Angiography–Based Assessments and Challenges in Standardization
American Journal of Ophthalmology 2025cited by 6position: middledoi
Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema
Ophthalmology 2025cited by 5position: lastdoi
Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases
Graefe s Archive for Clinical and Experimental Ophthalmology 2024cited by 34position: firstdoi
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Eye 2024cited by 11position: middledoi
Large language models and their impact in ophthalmology
The Lancet Digital Health 2023cited by 142position: middledoi
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
Ophthalmology Science 2023cited by 10position: middledoi
Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis
Eye 2022cited by 74position: lastdoi
The 5 min meta-analysis: understanding how to read and interpret a forest plot
Eye 2022cited by 64position: middledoi
Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis
Eye 2022cited by 31position: middledoi
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials
Eye 2022cited by 6position: firstdoi
AB026. Referrals from optometry—a comparative study (the R.O.C.S study)
Annals of Eye Science 2018cited by 0position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Charles C. Wykoff · Nune Eye Hospital7 papers (2022–2025)Sobha Sivaprasad · UK Biobank7 papers (2022–2025)Robyn H. Guymer · CHU Dijon Bourgogne5 papers (2022–2025)Mark Phillips · University of Iowa4 papers (2022–2022)Tien Yin Wong · Neuroscience Research Australia4 papers (2022–2025)Srinivas R. Sadda · University of California, Los Angeles4 papers (2024–2025)Peter K. Kaiser · Cleveland Clinic4 papers (2022–2025)David Sarraf · University of California, Los Angeles4 papers (2022–2025)Sunir J. Garg · Cleveland Clinic Lerner College of Medicine4 papers (2022–2025)Keean Nanji · McMaster University3 papers (2025–2025)Mohit Bhandari · McMaster University3 papers (2022–2022) · 3 papers (2022–2022)Enrico Borrelli · CTO Hospital3 papers (2025–2025)Frank G. Holz · Tsinghua University3 papers (2022–2022)David Steel · University of Newcastle Australia3 papers (2022–2025)Samantha Fraser‐Bell · The University of Sydney2 papers (2022–2025)Chui Ming Gemmy Cheung · SingHealth2 papers (2022–2025)Jim Shenchu Xie · McMaster University2 papers (2022–2025)Rishi P. Singh · Massachusetts Eye and Ear Infirmary2 papers (2022–2022)Amin Hatamnejad · McMaster University2 papers (2025–2025)